It currently makes three drugs that contain semaglutide, including: Wegovy, a once-weekly injectable medicine for weight loss and cardiovascular risk reduction Ozempic, a once-weekly injectable medicine for Type 2 diabetes and cardiovascular risk reduction, often prescribed off-label (for a non-FDA-approved use) for weight loss Rybelsus, a daily oral medicine for managing blood sugar levels in people with Type 2 diabetes, and sometimes prescribed off-label for weight loss These three brand-name medicines are the only FDA-approved semaglutide products
You can learn more about what to look out for and when to seek medical attention here
Search ClinicalTrials.gov for Retatrutide studies recruiting in Canada
Further, a majority of the sample (82.6%) was White/Caucasian, and 80% of participants reported that GLP-1RA use resulted in greater weight loss than conventional programs
Stay hydrated since dehydration can worsen nausea
Antioxidant Protection: Glutathione & Vitamin C combat free radicals